R&D
Slideshows
-
Bio News | Breaking News | Facilities | R&D
Solvias Announces New Biotech Site in North Carolina
The 50,000-square-foot facility will serve as Solvias’ North American hub for large molecule analytical services.05.06.24
-
Breaking News | Collaborations & Alliances | R&D
Scenic Biotech Enters Research Collaboration with Bristol Myers Squibb
Aims to accelerate the development of BMS’ drug targets by identifying target biology for indication selection and expansion.04.30.24
-
Breaking News | Drug Discovery | Industry News | R&D
Ono Pharmaceutical to Acquire Deciphera for $2.4B
Will enable ONO to build a robust presence in oncology, one of its key priority areas.04.29.24
-
Breaking News | Collaborations & Alliances | R&D
Modalis Joins the Ginkgo Technology Network
Grants Ginkgo’s customers access to Modalis’ proprietary epigenome modulation technology, CRISPR-GNDM.04.12.24
-
Breaking News | R&D
Rare Cancer Research Foundation Partners with Spanios to Advance Cancer Research
Aim to catalyze the discovery of new biomarkers and validate therapeutic approaches previously inaccessible to rare cancer patients.04.04.24
-
Breaking News | Clinical Trials | R&D
WCG Launches New Application on Its ClinSphere Technology Platform
New solution is designed to alleviate the burdens faced by sites and investigators in the assessment process.04.04.24
-
APIs | Capsules | Drug Development | Formulation Development | R&D | Scale-up/Technology Transfer
Why Sofgen Pharmaceuticals?
Integrated services in development, scale up, commercial manufacturing and packaging.04.04.24
-
Bio News | Breaking News | Collaborations & Alliances | R&D
BostonGene Named Akoya Biosciences' Qualified CRO
Will offer end-to-end spatial biology solutions to life sciences researchers for advanced spatial proteomics analysis.03.20.24
-
Breaking News | R&D
Parexel Announces CEO Transition
Jamie Macdonald will retire and transition his role as CEO to the company’s COO and Growth Officer Peyton Howell.03.18.24
-
Breaking News | Promotions & Moves | R&D
CRS Clinical Research Services Appoints Dr. Elisabeth Lackner as CEO
Dr. Lackner is a highly experienced and well-respected global thought leader with over 20 years of experience in the healthcare industry.03.15.24
-
R&D | Scale-up/Technology Transfer
Novel Therapeutic Manufacturing Trends
This webinar will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages.03.04.24
-
Breaking News | Drug Development | Industry News | R&D
CoreRx to Acquire Societal CDMO in $130M Deal
Will create an enhanced CDMO with broad capabilities spanning early-stage formulation development through commercial manufacturing and packaging.02.29.24
-
Breaking News | Collaborations & Alliances | R&D
Viatris and Idorsia Enter R&D Collaboration
Viatris to receive exclusive global development & commercialization rights to 2 Phase 3 assets as well as the potential to add additional assets in the future.02.28.24
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | R&D
Medidata and Thermo Fisher’s PPD Research Business Renew Relationship
Aim to complete studies faster, boost drug development productivity, and bring treatments to patients sooner.02.28.24
-
Breaking News | Drug Discovery | Promotions & Moves | R&D
LenioBio Names New CTO and CCO
Welcomes Kathrin Knauf as Chief Technology Officer and Malene Linderoth as Chief Commercial Officer.02.22.24
-
Bio News | Breaking News | Drug Development | Drug Discovery | R&D
AbbVie & Tentarix Partner on Conditionally-Active Biologics for Oncology & Immunology
Will integrate AbbVie's expertise in oncology and immunology with Tentarix's proprietary Tentacles platform.02.22.24
-
Breaking News | R&D
Introducing Alys Pharmaceuticals: A New Immuno-Dermatology Focused Company
Boasts a pipeline of programs and platforms targeting multiple dermatological indications.02.13.24
-
Breaking News | Preclinical Outsourcing | Promotions & Moves | R&D
StageBio Names David Bruning as CEO
Bruning brings over 25 years of leadership experience within product-based and preclinical testing services companies.02.12.24
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | R&D
Orexo AB Advances Exploratory Feasibility Study with Sobi
Aims to evaluate if the AmorphOX drug delivery platform can add unique properties to one of Sobi's biomolecules.02.12.24
-
Breaking News | Clinical Trials | Collaborations & Alliances | R&D
Saama Expands Collaboration with Pfizer to Expedite Clinical Research
Will leverage cutting-edge, AI-based technologies across Pfizer’s R&D portfolio.02.12.24
